Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss Following Partial, Near-Total, and Total Pancreatectomy in Patients Without Diabetes at Baseline: A Monocentric Ambispective Observational Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time. The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS. Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection. Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients (≥18 years)

• No diabetes mellitus at baseline

• Undergoing partial, near-total, or total pancreatectomy at the study center

• Availability of clinical and metabolic data according to study component

• Written informed consent for the prospective component

Locations
Other Locations
Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING
Rome
Contact Information
Primary
Teresa Mezza, MD, PhD
teresa.mezza@policlinicogemelli.it
06 30156664
Time Frame
Start Date: 2026-07-20
Estimated Completion Date: 2041-05
Participants
Target number of participants: 579
Treatments
Prospective Cohort
Prospectively enrolled adult patients without diabetes at baseline undergoing partial, near-total, or total pancreatectomy at the study center.
Retrospective Cohort
Retrospective cohort of adult patients without diabetes at baseline who underwent pancreatic surgery at the study center.
Ambispective Cohort
Patients without diabetes at baseline with retrospective baseline data and prospective postoperative follow-up after pancreatic surgery.
Sponsors
Collaborators: European Foundation for the Study of Diabetes
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

This content was sourced from clinicaltrials.gov